Becapio

BecapioBecapio
Becapio

Becapio

Developing a non-invasive therapy for fecal incontinence to improve patient well-being and quality of life.

Website
DR 4.12022Active4Tel Aviv, Israel
Rate
Advertise here

About

BeCapio develops a non-invasive, combined solution for fecal incontinence, also known as accidental bowel leakage. Their system includes a reusable control unit that generates electrical pulses to stimulate anal sphincters and pelvic muscles, and a disposable anal patch with skin electrodes. This technology aims to provide immediate leak prevention, on-demand muscle reinforcement, and long-term improvement for the 10% of middle-aged adults affected by this condition.
Frequently asked

What does Becapio do?

BeCapio develops a non-invasive, combined solution for fecal incontinence, also known as accidental bowel leakage. Their system includes a reusable control unit that generates electrical pulses to stimulate anal sphincters and pelvic muscles, and a disposable anal patch with skin electrodes. This technology aims to provide immediate leak prevention, on-demand muscle reinforcement, and long-term improvement for the 10% of middle-aged adults affected by this condition.

What is Becapio's revenue?

StartupHub estimates Becapio's annual revenue at $1.2M (range $680K to $2.1M, 68% confidence), based on comparable companies in the sector.

Where is Becapio headquartered?

Becapio is headquartered in Tel Aviv, Israel.

When was Becapio founded?

Becapio was founded in 2022.

What industry does Becapio operate in?

Becapio operates in Healthcare, MedTech, HealthTech, Medical Device, Gastroenterology, Urology.

How many employees does Becapio have?

Becapio has approximately 4 people on record.

HEADCOUNT
4
DOMAIN RATING
4.1
Comments

No comments yet. Be the first to share your take.